SOPHION BIOSCIENCE A/S: Financial statements 2015
CVR: 10021065
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
SOPHION BIOSCIENCE A/S (CVR 10021065) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 87,841,000 and a net result of DKK 8,732,000. The profit margin was 9.9%. Equity in the 2015 report amounted to DKK 124,415,000. The solvency ratio was 85.1%.
- Revenue
- DKK 87,841,000
- Gross Profit
- DKK 56,015,000
- Profit/Loss
- DKK 8,732,000
- Equity
- DKK 124,415,000
- Total Assets
- DKK 146,275,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 87.8 mio. | 56 mio. | 8.7 mio. | 124.4 mio. | - |
| 2013 | 83.4 mio. | 54 mio. | 18.3 mio. | 105.8 mio. | - |
Official annual report
How creditworthy is SOPHION BIOSCIENCE A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of July 13, 2015, Carsten Kronsbjerg Faltum has joined the board of directors of SOPHION BIOSCIENCE A/S.
As of July 13, 2015, Morten Sunesen has left the board of directors of SOPHION BIOSCIENCE A/S.
As of July 6, 2015, Carsten Kronsbjerg Faltum is registered as adm. dir. of SOPHION BIOSCIENCE A/S.
As of July 6, 2015, Morten Sunesen has stepped down as adm. dir. of SOPHION BIOSCIENCE A/S.
SOPHION BIOSCIENCE A/S has published its annual report for 2014.
About SOPHION BIOSCIENCE A/S
SOPHION BIOSCIENCE A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Michel Krall Jürgens. The board consists of Harald Høegh (chair), Eirik Lauglo, Gustaf Peter Reinhold von Ehrenheim and Peter Max. The company is owned by Sapphire Bioscience Holding ApS. The company has 41 employees (2018). In 2025, the company reported a gross profit of DKK 102,112,000 and a net result of DKK 4,354,000 compared with DKK 39,127,000 the year before. Equity in the 2025 report amounted to DKK 178,418,000.